Qualigens Pharma Private Limited - Due diligence report

A 360° intelligence report on Qualigens Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth an…

2013-10-10 Khalapur, Maharashtra Active Unlisted Active Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Qualigens Pharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
91/100
Trust Score
Low Risk

Qualigens Pharma Private Limited is assessed as Low Risk with a Trust Score of 91/100. Qualigens Pharma Private Limited is an active private limited indian non-government company incorporated in 2013, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 22 Nov 2026 from the latest processed filings. Qualigens Pharma Private Limited snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
91/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
81/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 0 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 4 open ( 48.0 cr ) · 0 satisfied ( 12.5 cr ).

Banking relationships (from registered charges)
LenderChargesAmount
Others3 48.0 cr
Axis Bank Limited1 48.0 cr
Compliance Score: 81/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • Litigation present in 1 court forum(s).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
AJIT JAIN 01234567 Director 01/04/2018 6 yrs Approved
ANKIT SURESH PAHARIA 01234567 Director 01/04/2018 6 yrs Approved
AAYUSH JAIN 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2025 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Profit expanded 24% year-on-year.
Asset base grew 0.86 - capacity expansion.
Net margin improved to 61%.
EPFO headcount growing - hiring signal.
Operating for 13+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
4 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence87/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment92/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 4 open charge(s) already registered.
  • Compliance record supports lending.
Investor view94/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 5 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
24 Jul 2024
Charge created
Others - 5.00 cr
22 Apr 2021
Charge created
Axis Bank Limited - 11.00 cr
15 Dec 2020
Director ceased
AAYUSH JAIN
02 Mar 2020
Securities allotted
548080 Equity Shares Without Differential Rights - 54.81 Lakh raised
27 Feb 2020
Charge created
Others - 2.24 cr
17 Jul 2019
Charge created
Others - 30.75 cr
28 Feb 2019
Director ceased
SURESH SOMCHAND SHAH
Director ceased
SUMATIPRAKASH MADANLAL JAIN
01 Aug 2017
Director appointed
AAYUSH JAIN (Director)
21 Mar 2016
Director ceased
ANU YADAV
10 Mar 2016
Director appointed
AJIT JAIN (Director)
30 Mar 2015
Securities allotted
990000 Equity Shares Without Differential Rights - 99.00 Lakh raised
10 Oct 2013
Incorporated
Registered with Roc Mumbai
10

Key Observations

Auto-generated from the data above
Revenue grew 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Debt-to-equity stands at 24% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2025 annual return.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
Approximately 49 employees on EPFO payroll records.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Yeoman Marine U35999MH2015PTC268155 Mumbai, Maharashtra, India
Srvs Solars Limited U01112CT1998PLC012646 Raipur, Chattisgarh, India
Cummins U29190DL2012PTC230162 Okhla, Delhi, India
Awign U74999KA2016PTC164508 Bengaluru, Karnataka, India
Medhaj U14292UP2007PTC033550 Lucknow, Uttar Pradesh, India
Vega India Level And Pressure Measurement Private Limited U31900PN2011FTC140098 Pune, Maharashtra, India
Simar Infrastructures Limited U45200HR2009PLC039695 Panipat, Haryana, India
Ce Comfort Engineers Private Limited U29253DL2012PTC230551 Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Qualigens Pharma Private Limited before audits and certifications: compliance score 81/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Qualigens Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Qualigens Pharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 91/100, distress signals and MSME payment-delay disclosures - know whether Qualigens Pharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Qualigens Pharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Qualigens Pharma Private Limited an active company?

Qualigens Pharma Private Limited has MCA status “Active” with a compliance score of 81/100 (Low Risk).

Is Qualigens Pharma Private Limited financially healthy?

Qualigens Pharma Private Limited has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Qualigens Pharma Private Limited?

Its overall Trust Score is 91/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Qualigens Pharma Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Qualigens Pharma Private Limited have loans or charges against its assets?

4 open charge(s) are registered against its assets.

Is Qualigens Pharma Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 81/100 (Low Risk).

Is it risky to lend to Qualigens Pharma Private Limited?

Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.